Stock Details
AZN is AstraZeneca PLC's stock. Stock exchange NasdaqGS (Currency USD). Average price in 50 days is 72.56$. Average daily volumn in 3 months 4.04M. Market cap 224.79B

Stock symbol : AZN. Exchange : NasdaqGS. Currency : USD
Lastest price : 72.52$. Total volume : 3.48M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

AstraZeneca PLC (AZN)
Last Price

Previous Close71.79
Day Range72.31-72.90
Bid72.54 x 1k
Ask73.85 x 1.3k
Average Volume4.04M
Market Cap224.79B
52 Week Range52.65-76.56
Trailing P/E48.03
Foward P/E16.83
Dividend (Yield %)2.00%
Ex-Dividend Date2023-02-23

Financial Details

According to AstraZeneca PLC's financial reports the company's revenue in 2022 were 44.35B an increase( +18.92%) over the years 2021 revenue that were of 37.42B. In 2022 the company's total earnings were 3.29B while total earnings in 2021 were 112M( +2578.57%).

Loading ...


AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern,... Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc, as well as research collaboration with Sernova Corp. to evaluate novel potential therapeutic cell applications. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Market Cap:
Total Assets:
Total Cash:

News about "AstraZeneca PLC"

AstraZeneca PLC: Reaffirming BUY; strong product pipeline

Source from : Yahoo Finance - 3 days ago

AstraZeneca is a British-Swedish company with its main headquarters in the U.K. and regional headquarters in Sweden and the U.S. It focuses on treatments for respiratory, autoimmune, and metabolic ...See details»


AstraZeneca PLC (LON:AZN) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed?

Source from : Yahoo Finance - 13 days ago

AstraZeneca's (LON:AZN) stock is up by 4.2% over the past three months. However, the company's financials look a bit inconsistent and market outcomes are ultimately driven by long-term fundamentals, ...See details»

AstraZeneca PLC (NASDAQ: AZN): Whatโ€™s Next After The Stock Plunge?

Source from : stocksregister - 5 days ago

The trading price of AstraZeneca PLC (NASDAQ:AZN) closed lower on Tuesday, May 23, closing at $74.07, -0.51% lower than its previous close. Traders who pay close attention to intraday price movement ...See details»

Client Profile: AstraZeneca PLC

Source from : - 26 days ago

AstraZeneca Pharmaceuticals $1,300,000 Sarah Arbes Revolving Door Profiles Non Former Members of Congress AstraZeneca Pharmaceuticals $1,300,000 Elizabeth Brooks Revolving Door Profiles Non Former ...See details»

AstraZeneca PLC ADR

Source from : Wall Street Journal - 12 days ago

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...See details»

BRIEF-Astrazeneca PLC Reiterates Guidance For FY 2023 Total Revenue And Core EPS

Source from : Reuters - 1 month ago


AstraZeneca 1Q Profit Rose, But Decline in Covid-19 Drug Sales Hurt Revenue

Source from : Wall Street Journal - 1 month ago

AstraZeneca PLC on Thursday reported a rise in profit for the first quarter, but said a decline in sales of its Covid-19 medicines hurt revenue. The Anglo-Swedish pharma giant posted net profit of ...See details»

AstraZeneca PLC (AZN) Stock: Analyzing the Market Value

Source from : newsheater - 11 days ago

AstraZeneca PLC (NASDAQ: AZN) has a higher price-to-earnings ratio of 49.21x compared to its average ratio,, and the 36-month beta value for AZN is at 0.53. Analysts have varying views on the stock, ...See details»

What Does AstraZeneca PLCโ€™s (NASDAQ: AZN) Future Hold?

Source from : stocksregister - 20 days ago

AstraZeneca PLC (NASDAQ:AZN) traded at $75.01 at last check on Monday, 05/08/23, made a downward move of -0.43% on its previous dayโ€™s price. Looking at the stock we see that its previous close was $75 ...See details»

What Recent Market Trends Mean for AstraZeneca PLCโ€™s (AZN) Stock

Source from : newsheater - 5 days ago

The stock of AstraZeneca PLC (AZN) has seen a -1.61% decrease in the past week, with a -2.30% drop in the past month, and a 7.58% flourish in the past quarter. The volatility ratio for the week is ...See details»

Unusual Call Option Trade in Astrazeneca plc - ADR (AZN) Worth $261.13K

Source from : Nasdaq - 20 days ago

On May 10, 2023 at 11:08:34 ET an unusually large $261.13K block of Call contracts in Astrazeneca plc - ADR (AZN) was bought, with a strike price of $75.00 / share, expiring in 37 day(s ...See details»

AstraZeneca plc isnโ€™t the only way to play the worldโ€™s ageing population

Source from : The Motley Fool UK - 5 years ago

AstraZeneca (LSE: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines. The three main areas it ...See details»

AstraZeneca Plc (AZN) Q1 2023 Earnings Call Transcript

Source from : Money Morning - 1 month ago

Numbers today are in millions of U.S. 10 stocks we like better than AstraZeneca Plc When our analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a ...See details»

AstraZeneca PLC (AZN): Today's Featured Drugs Laggard

Source from : - 22 days ago

AstraZeneca was a leading decliner within the drugs industry, falling 52 cents (-1.1%) to $44.67 on average volume. AstraZeneca was a leading decliner within the drugs industry, falling 52 cents ...See details»